Artificial intelligence / news brief
DeepMind releases AlphaGenome 2 for cell-specific DNA analysis
- Event
- Published

Google DeepMind released AlphaGenome 2 through its API for non-commercial research, with commercial use in private preview. The model conditions predictions on specific tissues, cell types or states and was trained on more than 107 million cell profiles. DeepMind reports higher variant recall than its predecessor, but the results are author-evaluated and the model is not validated for clinical or diagnostic use.
Why it matters
Cell-specific predictions could help researchers prioritize disease-linked variants, while API-only access and absent clinical validation limit immediate use.
Sources
- AlphaGenome 2: Deciphering how cells read DNA to better understand disease (external site)Google DeepMind · primary source ·
- Google’s AlphaGenome 2 zooms in on the cellular roots of disease (external site)The Verge · coverage ·